David Gómez‐Almaguer

Research interests

Publications

• Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

  JAMA · 2024 · 10.1001/jama.2024.4783

• Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria

  Blood Advances · 2023 · 10.1182/bloodadvances.2022009129

• Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

  BMC Infectious Diseases · 2021 · 10.1186/s12879-021-06829-7

• Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis

  Blood · 2020 · 10.1182/blood.2020006252

• Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia

  Blood Advances · 2019 · 10.1182/bloodadvances.2019000722

• Evans syndrome: clinical perspectives, biological insights and treatment modalities

  Journal of Blood Medicine · 2018 · 10.2147/jbm.s176144

• Latin America: the next region for haematopoietic transplant progress

  Bone Marrow Transplantation · 2017 · 10.1038/bmt.2016.361

• The effect of intra‐articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis

  International Journal of Rheumatic Diseases · 2017 · 10.1111/1756-185x.13139

• Importance of Nutrition in the Treatment of Leukemia in Children and Adolescents

  Archives of Medical Research · 2016 · 10.1016/j.arcmed.2016.11.013

• Observational study of multiple myeloma in Latin America

  Annals of Hematology · 2016 · 10.1007/s00277-016-2866-9

• Cost Structure and Clinical Outcome of a Stem Cell Transplantation Program in a Developing Country: The Experience in Northeast Mexico

  The Oncologist · 2015 · 10.1634/theoncologist.2014-0218

• Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults

  Blood · 2014 · 10.1182/blood-2014-01-549360

• Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial

  Cytotherapy · 2014 · 10.1016/j.jcyt.2014.01.008

• High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia

  European Journal Of Haematology · 2013 · 10.1111/ejh.12102

• Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients

  Diabetology & Metabolic Syndrome · 2013 · 10.1186/1758-5996-5-18

• Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

  Blood · 2013 · 10.1182/blood-2012-08-449918

• Danazol as first-line therapy for aplastic anemia

  Annals of Hematology · 2011 · 10.1007/s00277-011-1163-x

• Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias

  Blood · 2010 · 10.1182/blood-2010-06-291831

• Dimethyl Sulfoxide-Induced Toxicity in Cord Blood Stem Cell Transplantation: Report of Three Cases and Review of the Literature

  Acta Haematologica · 2009 · 10.1159/000227267

• Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

  Bone Marrow Transplantation · 2008 · 10.1038/bmt.2008.90

• Alemtuzumab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

  Transplantation and Cellular Therapy · 2007 · 10.1016/j.bbmt.2007.08.052

• Sub-Optimal Fetal Iron Acquisition under a Maternal Environment

  Archives of Medical Research · 2005 · 10.1016/j.arcmed.2005.03.023

• Reduced-intensity stem cell transplantation in children and adolescents: The Mexican experience

  Transplantation and Cellular Therapy · 2003 · 10.1016/s1083-8791(03)70004-4

• Results of an outpatient‐based stem cell allotransplant program using nonmyeloablative conditioning regimens

  American Journal of Hematology · 2001 · 10.1002/ajh.1051

• Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases

  Bone Marrow Transplantation · 2000 · 10.1038/sj.bmt.1702100

Current projects

No projects listed.